To validate that the upregulation of EphA2 by PTEN loss is not restricted to a single cell line or breast cancer, we conducted PTEN siRNA knockdown in two different cancer cell lines: HCT116 (colorectal cancer) and PEO1 (ovarian cancer). This evidence concerns the gene EPHA2 and breast cancer.